Figure 3 — Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ42 decline in non-demented elders

Research Paper|Volume 11, Issue 15|pp. 5433–5444

Genome-wide association study identifies CBFA2T3 affecting the rate of CSF Aβ₄₂ decline in non-demented elders

100%

Figure 3.Effects of CBFA2T3 rs13333659-T on cognitive performance and hippocampal volume over time. Data from linear mixed-effects models adjusted for age, gender, educational level, APOE ε4 genotype, disease status, follow-up duration, as well as intracranial volume for hippocampal volume. ADAS-cog 11 indicates Alzheimer Disease Assessment Scale-cognitive subscale.